Page last updated: 2024-09-03

gefitinib and daidzein

gefitinib has been researched along with daidzein in 1 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(daidzein)
Trials
(daidzein)
Recent Studies (post-2010) (daidzein)
5,2315662,9191,885136753

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)daidzein (IC50)
rac GTPase-activating protein 1 isoform aHomo sapiens (human)91.26
Estrogen receptorHomo sapiens (human)2.97
Aldehyde dehydrogenase, mitochondrialHomo sapiens (human)9
UDP-glucuronosyltransferase 1A1 Homo sapiens (human)7.3
TransporterRattus norvegicus (Norway rat)0.45
Estrogen receptor betaHomo sapiens (human)1.6568

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chang, YC; Chen, MC; Chen, RJ; Huang, CY; Kuo, CH; Kuo, WW; Mhone, TG; Shih, TC; Wang, TF; Yeh, CM1

Other Studies

1 other study(ies) available for gefitinib and daidzein

ArticleYear
Daidzein Synergizes with Gefitinib to Induce ROS/JNK/c-Jun Activation and Inhibit EGFR-STAT/AKT/ERK Pathways to enhance Lung Adenocarcinoma cells chemosensitivity.
    International journal of biological sciences, 2022, Volume: 18, Issue:9

    Topics: Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Isoflavones; Lung Neoplasms; MAP Kinase Signaling System; Mice; Mice, Nude; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species

2022